Given the insensitivity of some GBMs to radio- and chemotherapy (temozolomide) and the hypothesis that glioma stem cells cause resistance to drug therapy, we investigated whether miR-211 endows radiosensitivity to glioma cancer stem cells by synergistic downregulation of MMP-9. This evidence concerns the gene MMP9 and central nervous system cancer.